Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition

BACKGROUND: Plasma β-amyloid (Aβ) is a potential candidate for an Alzheimer’s disease (AD) biomarker because blood is an easily accessible bio-fluid, which can be collected routinely, and Aβ is one of the major hallmarks of AD pathogenesis in the brain. However, the association between plasma Aβ lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jong-Chan, Han, Sun-Ho, Cho, Hyun Jin, Byun, Min Soo, Yi, Dahyun, Choe, Young Min, Kang, Seokjo, Jung, Eun Sun, Won, Su Jin, Kim, Eun Hye, Kim, Yu Kyeong, Lee, Dong Young, Mook-Jung, Inhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361707/
https://www.ncbi.nlm.nih.gov/pubmed/28330509
http://dx.doi.org/10.1186/s13195-017-0248-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361707/
https://www.ncbi.nlm.nih.gov/pubmed/28330509
http://dx.doi.org/10.1186/s13195-017-0248-8

Ejemplares similares